Tight control of glycaemia in critically ill patients

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 5, Issue 5, 2002, Pages 533-537

  Preiser, Jean Charles ^a,d   Devos, Philippe ^b   Van Den Berghe, Greet ^c  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d RHMS Tournai ^*  (Belgium)

Author keywords

Carbohydrate; Infection susceptibility; Insulin; Myocardial ischaemia; Stroke

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT;

CONTROLLED STUDY; CRITICAL ILLNESS; DIABETES MELLITUS; DISEASE ASSOCIATION; DOSE TIME EFFECT RELATION; DRUG DOSE REGIMEN; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN TREATMENT; INTENSIVE CARE; MORTALITY; MULTIPLE ORGAN FAILURE; OUTCOMES RESEARCH; REVIEW; SEPSIS; BLOOD; BRAIN ISCHEMIA; HEART MUSCLE ISCHEMIA; HYPERGLYCEMIA; INFECTION; INTENSIVE CARE UNIT; LENGTH OF STAY; TREATMENT OUTCOME;

BLOOD GLUCOSE; BRAIN ISCHEMIA; CRITICAL ILLNESS; HOSPITAL MORTALITY; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFECTION; INSULIN; INTENSIVE CARE UNITS; LENGTH OF STAY; MYOCARDIAL ISCHEMIA; TREATMENT OUTCOME;

EID: 0036728091     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-200209000-00012     Document Type: Review

References (33)

1. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemic. Crit Care Clin 2001; 17:107-124. A review of the literature, very comprehensive and with a large description of the pathophysiology.
2. Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrlnol Metab 2001; 15:533-551. A detailed description of the pathophysiology of stress-induced hyperglycaemia.
3. Vasa FR, Molitch ME. Endocrine problems in the chronically critically ill patient. Clin Chest Med 2001; 22:193-208. A review of most endocrine problems commonly suspected in long-term critically ill patients, including hyperglycaemia, alterations in thyroid function, adrenal insufficiency, alterations in calcium and sodium balance.
4. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the surgical intensive care unit. N Engl J Med 2001; 345:1359-1367. A large randomized prospective clinical study of 1548 critically ill surgical patients comparing a conventional therapy with intensive insulin therapy. Morbidity and mortality were widely reduced in the intensive therapy group.
5. Fietsam RJ, Bassett J, Glover JL. Complications of coronary artery surgery in diabetic patients. Am Surg 1991; 57:551-557.
6. Pozzilli P, Leslie RD. Infections and diabetes: mechanisms and prospects for prevention. Diabet Med 1994; 11:935-941.
7. Gore DC, Chinkes D, Heggers J, et al. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 2001; 51:540-544. Retrospective study on 58 paediatric severely burned patients. Patients with poor glucose control (more than 40% of plasma glucose values >8 mmol/l) had a significantly greater incidence of positive blood cultures, less percentage of skin graft take and greater mortality than tightly controlled patients.
8. Mowlavi A, Andrews K, Milner S, et al. The effects of hyperglycemia on skin graft survival in the burn patient. Ann Plast Surg 2000; 45:629-632.
9. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999; 67:352-360.
10. Zerr KJ, Furnary AP, Grunkemeier GL, et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997; 63:356-361.
11. Rassias AJ, Marrin CA, Arruda J, et al. Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesth Analg 1999; 88:1011-1016.
12. Kwoun MO, Ling PR, Lydon E, et al. Immunologic effects of acute hyperglycemia in nondiabetic rats. JPEN J Parenter Enteral Nutr 1997; 21:91-95.
13. Nielson CP, Hindson DA. Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes 1989; 38:1031-1035.
14. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999; 26:259-265.
15. Rayfield EJ, Ault MJ, Keusch GT, et al. Infection and diabetes: the case for glucose control. Am J Med 1982; 72:439-450.
16. Hostetter MK, Lorenz JS, Preus L, Kendrick KE. The iC3b receptor on Candida albicans: subcellular localization and modulation of receptor expression by glucose. J Infect Dis 1990; 161:761-768.
17. Black CT, Hennessey PJ, Andrassy RJ. Short-term hyperglycemia depresses immunity through nonenzymatic glycosylation of circulating immunoglobulin. J Trauma 1990; 30:830-832.
18. Ferrando AA, Chinkes DL, Wolf SE, et al. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg 1999; 229:11-18.
19. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355:773-778.
20. Bolk J, van der Ploeg T, Cornel JH, et al. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 2001; 79:207-214. Prospective study of the relationship between admission plasma glucose level and mortality in 336 patients with acute myocardial infarction. One year mortality rate was 19.3% and rose to 44% in patients with glucose levels higher than 11.1 mmol/l. Multivariate analysis revealed an independent effect of glucose level on mortality.
21. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999; 99:2626-2632.
22. Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose: independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 1999; 22:1827-1831.
23. Akbari CM, Saouaf R, Barnhill DF, et al. Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia. J Vasc Surg 1998; 28:687-694.
24. Williams SB, Goldfine AB, Timimi FK, et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 1998; 97:1695-1701.
25. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32:2426-2432. A meta-analysis of the relationship between glucose levels and outcome of stroke. Thirty-day mortality and poor functional recovery were correlated with high admission glucose level, except for haemorrhagic stroke.
26. Kagansky N, Levy S, Knobler H. The role of hyperglycemia in acute stroke. Arch Neurol 2001; 58:1209-1212. A complete review of the recent animal and human studies on ischaemic stroke and hyperglycaemia, with emphasis on the physiopathology.
27. Scott JF, Robinson GM, French JM, et al. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke 1999; 30:793-799.
28. Sieber FE, Traystman RJ. Special issues: glucose and the brain. Crit Care Med 1992; 20:104-114.
29. Bruno A, Biller J, Adams HPJ, et al. Acute blood glucose level and outcome from ischemic stroke: Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 1999; 52:280-284.
30. Rovlias A, Kotsou S, The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 2000; 46:335-342; discussion 342-343.
31. Schurr A, Payne RS, Tseng MT, et al. The glucose paradox in cerebral ischaemia: new insights. Ann N Y Acad Sci 1999; 893:386-390.
32. Hamilton MG, Tranmer BI, Auer RN. Insulin reduction of cerebral infarction due to transient focal ischemia. J Neurosurg 1995; 82:262-268.
33. Voll CL, Whishaw IQ, Auer RN. Postischemic insulin reduces spatial learning deficit following transient forebrain ischemia in rats. Stroke 1989; 20:646-651.